业绩稳 实体经济“基本盘”地位巩固

Core Viewpoint - The performance of companies has shown "counter-cyclical" growth despite challenges such as declining product prices and rising raw material costs, with a focus on steady growth policies and improving market expectations [1][9]. Group 1: Company Performance - Guangji Pharmaceutical reported a net profit increase of 47.50% in 2021, despite vitamin B2 prices being at historical lows and rising corn starch costs [2][10]. - As of April 18, 2021, 64.18% of 3920 listed companies reported a year-on-year increase in net profit [2][10]. - The overall market shows a solid foundation, with 4782 listed companies and a market value of 80.7 trillion yuan, reflecting a growth of 33.4% and 85.3% since the end of 2018 [3][11]. Group 2: Industry Challenges - In 2022, companies faced new challenges from domestic COVID-19 outbreaks and geopolitical conflicts, leading to a slowdown in growth rates [4][12]. - The first quarter of 2022 saw a significant decrease in growth rates, with net profit growth of only 3.76% for some companies compared to previous years [4][12]. - The automotive industry, particularly in the electric vehicle sector, has experienced price increases due to rising raw material costs and supply chain disruptions [5][13]. Group 3: Strategic Responses - Companies are focusing on internal reforms and efficiency improvements to navigate challenges, with many adopting hedging strategies against raw material price increases [6][14]. - The construction of "5G + smart manufacturing" demonstration zones aims to reduce energy consumption and improve economic efficiency [16]. - R&D investment remains strong, with 1797 companies reporting a total of 690.23 billion yuan in R&D expenses, a 27.11% increase year-on-year [7][15].